Heru

Heru is a medical software company that has introduced a pioneering multi-modal wearable solution, revolutionizing healthcare by offering several vision exams within a single platform. Its dark adaptation exam and contrast sensitivity exams establish a market-leading AMD portfolio, aiding in the early detection and monitoring of disease progression. The company, founded in 2018, is based in the United States and has recently secured a $30.00M Series A investment led by D1 Capital Partners, Krillion Ventures, Maurice Ferre, M.D., Open Opportunity Fund, and Fred Moll, M.D at 20 May 2021.

Heru's long-term vision includes the development of therapeutic applications for personalized augmented vision correction. As an award-winning platform, Heru's comprehensive solution aligns with the current standard of care and surpasses traditional standards in usability, cost, size, and portability. Born out of the University of Miami’s Bascom Palmer Eye Institute, Heru is at the forefront of the new reality in vision care, leveraging commercially available AR/VR head-mounted displays to redefine vision exams.